tykhr
sign in
free sign up
Lixte Biotechnology Holdings Inc
Biotechnology
Healthcare
LIXT
2.72 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
5.57
52 week high
6.01
high
5.68
52 week low
0.00
low
5.13
growth
177.66 %
previous Close
5.42
P/E ratio
market cap
14.68 M
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
-775.67 K
-9.32 %
eps
0.00 %
-1.01 %
eps surprise
0.00 %
net profit margin
-77567300.00 %
0.00 %
operating incoming
-774.81 K
-9.60 %
net change in cash
-497.49 K
-243.89 %
cash on hand
887 K
-35.93 %
cost of revenue
0.00 %
top